DC Chemicals · Product datasheet

Capromorelin — Datasheet

CAT. NO. DC7615

Product page and current package options

ParameterValue
Chemical NameCapromorelin tartrate
CAS No.193273-69-7
SynonymsN-{2-[(3aS)-3a-benzyl-2-methyl-3-methylidene-2,3,3a,4,6,7-hexahydro-5H-pyrazolo[4,3-c]pyridin-5-yl]-1-(benzyloxy)-2-oxoethyl}-2-methylalaninamide 2,3-dihydroxybutanedioate (1:1);(2R,3R)-2,3-Dihydroxysuccinic acid - N-{2-[(3aS)-3a-benzyl-2-meth yl-3-methylene-2,3,3a,4,6,7-hexahydro-5H-pyrazolo[4,3-c]pyridin-5 -yl]-1-(benzyloxy)-2-oxoethyl}-2-methylalaninamide (1:1);N-{2-[(3aS)-3a-benzyl-2-methyl-3-methylidene-2,3,3a,4,6,7-hexahydro-5H-pyrazolo[4,3-c]pyridin-5-yl]-1-(benzyloxy)-2-oxoethyl};2-Amino-N-[(1R)-2-[(3aR)-2,3,3a,4,6,7-hexahydro-2-methyl-3-oxo-3a-(phenylmethyl)-5H-pyrazolo[4,3-c]pyridin-5-yl]-2-oxo-1-propanamide (2R,3R)-2,3-dihydroxybutanedioate;CP 424391-18;CP-424391 tartrate;CaproMorelin Tartrate;Capromorelin (Tartrate);Capromorelin tartrate [USAN];4150VMF5EP;Capromorelin tartrate (USAN);2-amino-N-((R)-1-((R)-3a-benzyl-2-methyl-3-oxo-2,3,3a,4,6,7-hexahydro-5H-pyrazolo[4,3-c]pyridin-5-yl)-3-(benzyloxy)-1-oxopropan-2-yl)-2-methylpropanamide (2R,3R)-2,3-dihydroxysuccinate;N-[(2R)-1-[(3aR)-3a-benzyl-2-methyl-3-oxo-6,7-dihydro-4H-pyrazolo[4,3-c]pyridin-5-yl]-1-oxo-3-phenylmethoxypropan-2-yl]
FormulaC32H41N5O10
M.Wt655.6954
SMILESO=C1[C@@]2(C([H])([H])C3C([H])=C([H])C([H])=C([H])C=3[H])C(C([H])([H])C([H])([H])N(C([C@@]([H])(C([H])([H])OC([H])([H])C3C([H])=C([H])C([H])=C([H])C=3[H])N([H])C(C(C([H])([H])[H])(C([H])([H])[H])N([H])[H])=O)=O)C2([H])[H])=NN1C([H])([H])[H].O([H])[C@@]([H
Purity>98%
Storage2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO

Biological Activity

Capromorelin Tartrate is an orally active, potent growth hormone secretagogue receptor (GHSR) agonist, with Ki of 7 nM for hGHS-R1a.

In Vitro

Capromorelin stimulates GH release in rat pituitary cell cultures with EC50 of 3 nM[2].

In Vivo

Dogs receiving capromorelin (30 mg/mL) have food consumption that is significantly greater than dogs treated with placebo. All dogs in the capromorelin group gain weight by 0.52 kg, more than that of placebo group[1]. Capromorelin shows enhanced intestinal absorption in rodent models and exhibits superior pharmacokinetic properties, including high bioavailabilities in two animal species [F(rat)=65%, F(dog)=44%][2]. Capromorelin stimulates GH release in anesthesized rat model, with ED50 of 0.05 mg/kg iv[2].

References & source

DC Chemicals original product information

Published experimental findings depend on the model and assay conditions. They do not guarantee equivalent performance in every application. For laboratory research use only.

Cart

Request quotation